CLASS II ONGOING Device recall · Reported 27 Nov 2024 · FDA Enforcement Report
Vue Pacs Diagnostic Viewer with Vue Pacs client recalled
Philips Medical Systems Technologies is recalling Vue Pacs Diagnostic Viewer with Vue Pacs client 12.1.5 to 12.2.8.454, distributed nationwide in the US. The recall was initiated on 10 Oct 2024 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-0497-2025
- FDA event ID
- 95604
- Recalling firm
- Philips Medical Systems Technologies, Haifa, N/A
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 10 Oct 2024
- FDA classified
- 20 Nov 2024
- Reported
- 27 Nov 2024
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Device Malfunction
- Device type
- Test Kits & Diagnostics
Timeline
| 10 Oct 2024 | Recall initiated by company | |
| 20 Nov 2024 | Classified by FDA | +41 days |
| 27 Nov 2024 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
A software issue affecting Philips Vue PACS may cause incorrect ischemic map and table value calculations when using the export function in the Perfusion Application for a Siemens CT perfusion study, resulting in misdiagnosis due to incorrect ischemic map and table values.
Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.
Product as listed by the FDA
Vue PACS Diagnostic Viewer with Vue PACS client 12.1.5 to 12.2.8.454 software Model Number: 1149418 Intended use is to provide completely scalable local and wide area PACS (Picture Archiving and Communication System) solutions for hospital and related institutions/sites.
Where it was distributed
US Nationwide and Worldwide Distribution Foreign: Country Argentina Australia Austria Belgium Brazil Chile China Colombia Denmark Finland France Germany Gibraltar Greece Guernsey Holy See (Vatican City State) Hong Kong Hungary Indonesia Ireland Israel Italy Japan Jersey Jordan Lebanon Malaysia Mexico Netherlands New Zealand Norway Oman Panama Philippines Poland Portugal Romania Saudi Arabia Serbia Slovenia Spain Sweden Switzerland Taiwan Thailand United Kingdom
Questions about this recall
Why was it recalled?
A software issue affecting Philips Vue PACS may cause incorrect ischemic map and table value calculations when using the export function in the Perfusion Application for a Siemens CT perfusion study, resulting in misdiagnosis due to incorrect ischemic map and table values.
Which lots are affected?
UDI-DI: (01)00884838100350(11)200221(10)12.2.5; (01)00884838100350(11)200812(10)12.2.6.0; (01)00884838100350(11)201207(10)12.2.6.100; (01)00884838100350(11)210303(10)12.2.6.200; (01)00884838100350(11)210518(10)12.2.6.201; (01)00884838100350(11)210729(10)12.2.6.300; (01)00884838100350(11)210502(10)12.2.8.0; (01)00884838100350(11)220112(10)12.2.8.100; (01)00884838100350(11)221213(10)12.2.8.200; (01)00884838100350(11)230301(10)12.2.8.210; (01)00884838100350(11)230320(10)12.2.8.300; (01)00884838100350(11)230608(10)12.2.8.310; (01)00884838100350(11)230718(10)12.2.8.400; (01)00884838100350(11)230810(10)12.2.8.401; (01)00884838100350(11)230824(10)12.2.8.317; (01)00884838100350(11)231019(10)12.2.8.412; (01)00884838100350(11)231108(10)12.2.8.403; (01)00884838100350(11)231129(10)12.2.8.413; (01)00884838100350(11)231214(10)12.2.8.414; (01)00884838100350(11)231204(10)12.2.8.420; (01)00884838100350(11)240101(10)12.2.8.415; (01)00884838100350(11)240116(10)12.2.8.421; (01)00884838100350(11)240204(10)12.2.8.422; (01)00884838100350(11)240226(10)12.2.8.424; (01)00884838100350(11)240311(10)12.2.8.426; (01)00884838100350(11)240407(10)12.2.8.440; (01)00884838100350(11)240425(10)12.2.8.450; (01)00884838100350(11)240613(10)12.2.8.451; (01)00884838100350(11)240715(10)12.2.8.452; (01)00884838100350(11)240715(10)12.2.8.454; (01)00884838100350(11)230926(10)12.2.8.410
Where was it sold?
US Nationwide and Worldwide Distribution Foreign: Country Argentina Australia Austria Belgium Brazil Chile China Colombia Denmark Finland France Germany Gibraltar Greece Guernsey Holy See (Vatican City State) Hong Kong Hungary Indonesia Ireland Israel Italy Japan Jersey Jordan Lebanon Malaysia Mexico Netherlands New Zealand Norway Oman Panama Philippines Poland Portugal Romania Saudi Arabia Serbia Slovenia Spain Sweden Switzerland Taiwan Thailand United Kingdom
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other Test Kits & Diagnostics recalls
All 2,663| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | DxC 500 AU Clinical Chemistry Analyzers: AU w/out ISE recalled | Beckman Coulter | Device Malfunction | Nationwide |
| Device | CLASS II | DxC 500i Clinical Analyzer Modules: DxC 500 AU Module w/ISE recalled | Beckman Coulter | Device Malfunction | Nationwide |
| Device | CLASS II | McKesson Consult hCG Urine Cassette recalled by Alere San Diego | Alere San Diego | Potency & Assay | Nationwide |
| Device | CLASS II | Systems/units containing affected recalled | Beckman Coulter Mishima K.K | Device Malfunction | Nationwide |
| Device | CLASS II | Fisher Scientific Sure-Vue Urine hCG recalled by Alere San Diego | Alere San Diego | Potency & Assay | Nationwide |